Dark Forest Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Dark Forest Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,770	Closed	-$384K	–	1365
2023 Q2	$384K	Buy	+1,770	New	+$379K	0.04%	726
2022 Q4	–	Sell	-165	Closed	-$37K	–	1570
2022 Q3	$37K	Buy	+165	New	+$33.4K	0.01%	552
2022 Q1	–	Sell	-954	Closed	-$125K	–	1877
2021 Q4	$125K	Buy	954 +172	+22%	+$22.2K	0.05%	309
2021 Q3	$96K	Buy	782 +72	+10%	+$8.31K	0.03%	395
2021 Q2	$81K	Buy	+710	New	+$83K	0.04%	368

Other funds holding KRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Dark Forest Capital Management's KRTX Position: Q3 2023 in Review

Dark Forest Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q3 2023, closing a stake of 1,770 shares — an estimated $384K sold.

Dark Forest Capital Management first reported a position in KRTX in Q2 2021 and held it in 5 quarters. The position peaked at $384K in Q2 2023. 256 funds tracked by Wall St. Rank hold KRTX as of Q3 2023.

Dark Forest Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Dark Forest Capital Management sold 1,770 Karuna Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $384K.
Dark Forest Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Dark Forest Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $384K in Q2 2023.
256 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Dark Forest Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.